Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain. [Efecto de Duloxetina 60 mg, Administrado una Vez al Dia, Frente a Placebo, en Pacientes con Lumbalgia Cronica]

Next Previous
Trial Profile

Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain. [Efecto de Duloxetina 60 mg, Administrado una Vez al Dia, Frente a Placebo, en Pacientes con Lumbalgia Cronica]

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Acronyms HMGC
  • Sponsors Eli Lilly and Company

Most Recent Events

  • 14 May 2010 Results published in the Journal of Pain.
  • 06 May 2010 Results presented at 29th Annual Scientific Meeting of the American Pain Society.
  • 04 Feb 2010 Actual number of patients changed from 395 to 401 according to Eli Lilly media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top